Registered Nurse in Altus, OK Accepting Medicare

6 Registered Nurse nurses found. Showing 1 - 6

Jorge Cardenas, PMHNP Registered Nurse - Medical-Surgical Medicare: Accepting Medicare Assignments Practice Location: 205 S Park Ln, Altus, OK 73521 Phone: 580-379-6650

Hildegard Long, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 215 W Commerce St, Altus, OK 73521 Phone: 580-480-0650

Daniel Dee Moore Jr., CRNA Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 N 1st St # 46, Altus, OK 73523 Phone: 580-481-5290

Erica Sollis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 215 W Commerce St, Altus, OK 73521 Phone: 580-480-0650

Zackary Cole Morgan, APRN-CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1200 E Pecan St, Altus, OK 73521 Phone: 580-379-5000    Fax: 580-379-5509

Jenne Gough, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 N Hudson St, Altus, OK 73521 Phone: 580-379-4085

News Archive

Researchers associate neuroimaging data with reading deficits in patients with left-sided stroke

Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.

Three Dutch life-science sectors announce joint investment to research on personalized medicine

The Netherlands' three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of MEUR 28 on innovative research targeted at bringing personalized medicine closer to reality.

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.

Investing in disease prevention receives majority support among Americans

Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF) released a new public opinion survey today that finds that 71 percent of Americans favor an increased investment in disease prevention and that disease prevention is one of the most popular components of health reform. Forty-four percent of Americans strongly favor investing more in prevention.

Read more Medical News

› Verified 9 days ago